Marketresearchnews

Sunday, 25 October 2020

Superdisintegrants Systems Market 2020 - Shares, Revenue, Analysis And Forecasts Till 2023

Superdisintegrants Systems Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

Market Synopsis

Market Research Future (MRFR) speculates that the global superdisintegrants systems market is slated to garner USD 576.2 million, grabbing a CAGR of 7.9% during the forecast period (2018 to 2023). Increased production of generic drugs is predicted to is estimated to favor the market growth in the coming years. Disintegrants are referred to as substances which are generally included in drug formula in order to allow proper disintegration of the tablet or capsule into dissolvable particles. Superdisintegrants are added to drug formulation to facilitate the dissolution of the capsule content into reduced particles. Crospovidone, sodium starch glycolate, and croscarmellose sodium are some of the widely used products.

Also Read : https://www.medgadget.com/2019/06/superdisintegrants-systems-market-2019-global-size-key-players-share-future-perspectivetechnologies-trends-competitive-landscape-and-analysis-by-forecast-to-2023.html

Market Potential and Pitfalls

The pharmaceutical sector is observed to grow at a breakneck and is becoming an important part of the healthcare sector owing to the increasing population of both pediatric as well as geriatric patients. Superdisintegrants help to treat patients of this demographic as these tablets can be swallowed easily. With the growth of the demographic, the market for Superdisintegrants is estimated to flourish. Generic drugs are also high in demand as patents are running out on popular drug brands, thereby opening up the pharmaceutical sector for rising entry of competition and increased manufacturing of generic drugs. This has further propelled the market demand for superdisintegrants across the globe.

Superdisintegrants are extensively used in the production of drugs aimed at pediatric and geriatric patients as they provide good efficacy and disintegration at low dosage. With the rising incidences of several chronic diseases coupled with the rapidly growing healthcare infrastructure, the market is considered to propel. Governments from several economies are focusing on prevention rather than treatment, which has triggered the consumption of pharmaceuticals, thereby fostering the market growth. Moreover, advanced R&D activities is contributing to the growth of the market. For instance, substances like gellan gum, soy polysaccharide, isapghula husk mucilage, karaya gum, and locust bean gum are some of the natural substances which can be used as superdisintegrants in solid dosage form.

On the contrary, lack of investment in research and development activities is predicted to deter the superdisintegrants systems market throughout the appraisal period.

Global Superdisintegrants Systems Market: Segmental Analysis

The global superdisintegrants systems market has been segmented on the basis of formulation, type, and therapeutic area.

By mode of type, the global superdisintegrants systems market has been segmented into natural disintegrants, synthetic superdisintegrants, and others. Among these, the synthetic Superdisintegrants occupies a major share as they are widely used in the formulation of drugs. On the other hand, natural Superdisintegrants are expanding at a rapid pace owing to the increased demand for natural ingredients.

By mode of formulation, the global superdisintegrants systems market has been segmented into tablets and capsules. Among these, the tablets command a major share as they are easy to consume.

By mode of therapeutic area, the global superdisintegrants systems market has been segmented into neurological diseases, gastrointestinal diseases, infectious diseases, oncology, hematological diseases, inflammatory diseases, and cardiovascular diseases. Among these, the gastrointestinal diseases occupy a major share owing to the demand for fast acting medicine for such kinds of diseases.

Regional Insights

Geographically, the superdisintegrants systems market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.

Among all the regions, the American region is considered go capture the largest market share, led by the U.S. The growth is credited to the presence of a well-developed healthcare infrastructure and prominent market players. Moreover, due to the rising prevalence of chronic diseases, the demand for drugs where superdisintegrants are required have increased, thereby influencing the market.

The Asia Pacific region is predicted to expand at the highest pace owing to the high concentration of rapidly emerging markets in this region. Country-level markets like India, China, and Japan have a high demand for drugs due to increased prevalence of chronic diseases. Moreover, with the presence of contract manufacturing organizations for pharmaceuticals and rapidly growing healthcare sector, the market for superdisintegrants systems is considered to foster.

Competitive Dashboard

The prominent players operating the global superdisintegrants systems market are Ashland Global Holdings Inc., Avantor Performance Materials LLC, Corel Pharma Chem, Roquette Freres, Asahi Kasei Corporation, Merck KGaA, JRS Pharma, BASF SE, DowDuPont Inc., and DFE Pharma.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/superdisintegrants-market-6663

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future, Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune – 411028 Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

The Healthcare Asset Management Market Staggering Double Digit Cagr Driven By Advanced & Cost Effective Technologies Forecasts Till 2023

Market Research Future adds the “Healthcare Asset Management Market Research Report - Forecast to 2023” report to their unique collection.

The global market for healthcare asset management is on a track of growth with 18.2% CAGR for the forecast period of 2018 to 2023. Market Research Future (MRFR) revealed factors that can influence the global market outcome. These factors are the constant demand for increasing patient safety, efficient handling of resources, and the inclusion of advanced technologies to ease the workflow. The rise in expenditure to provide better support to the healthcare sector is expected to take the market forward.

Also Read : https://www.benzinga.com/pressreleases/20/06/ab16164541/covid-19-drives-healthcare-asset-management-market-2020-technology-advancement-industry-size-swot

Healthcare Asset Management Market Segmentation:

The healthcare asset management market, as discussed by MRFR research analysts, includes an application, product, and end-user as segments. These segments have various factors analyzed in them, which are then backed by figures and charts to make the report more reliable for developing strategies.

By product, the global market has been segmented into radiofrequency identification (RFID) devices, real-time location systems (RTLS), and ultrasound & infrared tags. The real-time location systems (RTLS) segment includes hardware, software and services. The hardware segment comprises tags/badges and readers/interrogators.

The radiofrequency identification (RFID) devices are composed of hardware and software and services. The hardware segment encompasses readers/interrogators, tags, and accessories. The tags consist of passive tags and active tags. The passive tags segment includes ultra-high-frequency (UHF) tags, high-frequency (HF) tags, and low-frequency (LF) tags.

By application, the global market study has been segmented into hospital asset management and pharmaceutical asset management. The hospital asset management segment comprises staff management and infection control, patient management, temperature, and humidity monitoring, equipment tracking and management, and hand hygiene compliance. The pharmaceutical asset management segment relies on an assessment of drug anti-counterfeiting and supply chain management.

By end-user, the report includes laboratories, pharmaceutical companies, hospitals/clinics, and biotechnology.

Healthcare Asset Management Market Regional Analysis:

The Americas will dominate the global healthcare asset management market with greater contributions from North America. The US would contribute the most and the rise in their healthcare expenditure and improved infrastructural support will help the regional market growth. Major companies are also operating from the region, which is an impetus for the market.

Healthcare Asset Management Market Competitive Landscape:

The global market for healthcare asset management is witnessing a surge due to the contributions made by several market players like GE Healthcare, IBM Corporation, cenTrak, Airista Flow, Tyco Security Products., Intelligent InSites, Infor Inc., Radianse, JADAK (a Novanta Company), Siemens Healthineers, Motorola Solutions, Inc., Stanley Black & Decker, Inc., Sonitor Technologies, Ekahau, Inc., and others. The strategic decisions these companies make to increase their portfolio includes a detailed take on mergers, acquisitions, and collaborations. These companies have also increased their research expenditure, which will boost innovation and attract better launching and branding strategies. These can offer edge to the player that will help in staying ahead of peers. MRFR recorded these moves to make sure the market study remains holistic.

Healthcare Asset Management Industry News:

In May 2020, Sectoral Asset Management, a Montreal-based company, announced that they had received funding worth USD96million during the final funding round for their New Emerging Medical Opportunities IV.

In May 2020, Accruent announced that Cooper University Health Care is now ready to partner with Accruent’s Connectiv healthcare technology management (HTM) and Medical Device Security Analyzer (MDSA) software. The collaboration is to manage the healthcare asset at the Cooper University Health Care campus.

During the COVID-19 pandemic outbreak, the related industries may find this as an extra investment as they are grappling for funds to support their healthcare service providers and research and development teams. However, the ability of this tool to simplify workflow may turn the market favorable.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/healthcare-asset-management-market-6335

About Us:

Contact Us:

Market Research Future, Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune – 411028 Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cardiac Monitoring and Cardiac Rhythm Management Device Market Innovative Treatments, Key Methodologies, Size, Growth, Top Players Success Milestones And Forecasts To 2023

Cardiac Monitoring and Cardiac Rhythm Management Device Market report by MRFR contains all analytical and statistical transient regarding Market summary, Growth, Demand and Forecast analysis with penetrating summary and solution within the complex industry.

As per Market Research Future (MRFR) analysis, the global cardiac monitoring and cardiac rhythm management device market is estimated to grow at 4% CAGR from 2018 to 2023 (forecast period).

The cardiac monitoring device helps to monitor the patient’s cardiac activity, and the cardiac rhythm management device preserves normal cardiac rhythm in patients with irregular heart rate and rhythm disorder. Such devices play a significant role in the treatment of severe cardiac conditions, including heart failure, atrial flutter, atrial fibrillation, lack of oxygen supply to the heart muscle, recent heart attack indication, and other genetic defects, among others.

Also Read : https://www.benzinga.com/pressreleases/20/06/ab16185932/cardiac-monitoring-and-cardiac-rhythm-management-device-market-is-projected-to-register-cagr-of-4

Cardiac Monitoring and Cardiac Rhythm Management Device Market Dynamics

Factors such as rising cardiac disorders, changing lifestyles, technological developments in cardiac devices, awareness of cardiac disorders, healthcare services, and a growing amount of unmet medical needs in developed and undeveloped countries have contributed to an increase in the growth of this sector. Moreover, the development of new MRI-labelled devices and the economic growth in the Asia Pacific region is likely to push the market for cardiac monitoring devices during the forecast period.

Cardiac Monitoring and Cardiac Rhythm Management Device Market Segmentation

The market is segmented into types of cardiac devices, types of cardiac rhythm management devices, types of cardiac monitoring devices, and end-users.

The cardiac devices, based on types, are segmented into biventricular pacemaker, pacemaker, implantable cardiac loop recorder, and implantable cardioverter-defibrillator.

The cardiac monitoring devices, based on types, are segmented into Holter monitor, electrocardiogram (ECG), implantable loop recorder, cardiac output monitoring devices, and event monitor. Electrocardiogram (ECG) is further sub-segmented into a telelectro-cardiogram, lead ECG test, and wireless ECG.

The cardiac rhythm management devices, based on types, are segmented into defibrillators, cardiac resynchronization therapy devices, and pacemakers. Defibrillations are further sub-segmented into external defibrillators and implantable defibrillators.

Depending on the end-user, the market is segmented into hospitals, ambulatory surgical centers, and others.

Cardiac Monitoring and Cardiac Rhythm Management Device Market Regional Analysis

The global Cardiac Monitoring and Cardiac Rhythm Management Device Market has been segmented, by region, into the Americas, Europe, the Asia Pacific, and the Middle East and Africa.

North America will dominate the market for global cardiac monitoring and cardiac rhythm management devices during the forecast era. North America’s increasing investment in cardiac devices over the last few years has led to an increase in the market in this region. Growing numbers of cardiac patients, strengthened healthcare facilities, and advanced cardiac monitoring equipment technologies have boosted the demand for cardiac and cardiac rhythm management devices in North America.

The second-largest market for cardiac monitoring devices is expected to be the European market. Market growth in this region can be ascribed to government funding and support for the healthcare sector, coupled with increased research and development. In addition, a growing number of surgeries due to a changing lifestyle are propelling the growth of the market in this region.

The Asia Pacific is expected to be the fastest-growing market for cardiac monitoring devices during the forecast period due to the rising prevalence of cardiac disease, growing investment in healthcare, increasing geriatric population and the proliferation by market players in the region. The Asia Pacific competes strongly in the global market for cardiac monitoring devices by producing cost-effective products that are high in demand in both local and global markets.

The demand in the Middle East and Africa is projected to have the smallest market share in the global market for cardiac monitoring devices due to underdeveloped healthcare, lack of technical knowledge, and inadequate medical facilities.

Cardiac Monitoring and Cardiac Rhythm Management Device Market Key Players

Some of the leading participants in the global cardiac monitoring and cardiac rhythm management device market are Boston Scientific Corporation, Abiomed, Berlin Hearth, Brotionik SE and Co. KG, Cardiac Science Corporation, General Electric (GE), Jarvik Hearth. Inc, LivaNova plc, Koninklijke Philips N.V, Hill Rom Services Inc, Nihon Kohden Corporation, Medtronic plc, ReliantHeart Inc, Schiller, and Abbott.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/cardiac-monitoring-advance-technologies-global-market-6332

About Us:

Contact Us:

Market Research Future, Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune – 411028 Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

COVID-19 Diagnostics Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

COVID-19 Diagnostics Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

The global COVID-19 diagnostics market is growing pervasively. The major outburst of the COVID-19 virus in various regions across the globe is a significant driving force behind the growth of the market. The market growth attributes to the coronavirus pandemic rising at an alarming rate. Besides, spreading awareness about effective diagnostic procedures drives the growth of the market. Also, increasing research and development activities by the governments, non-profit organizations, and industry players foster market growth.

Moreover, aggressive strategies by top players for the development of new products and launches escalate the market growth to furthered height. According to Market Research Future (MRFR), the global COVID-19 diagnostics market valuation is poised to reach USD 96,293.9 MN by 2027, growing at 6.28% CAGR throughout the forecast period (2020–2027). Increasing COVID-19 cases and funds & support for research & development from the public and private sectors boost the market growth exponentially.

Also Read : https://www.benzinga.com/pressreleases/20/08/ab16996950/global-covid-19-diagnostics-market-to-witness-rising-product-launches-mrfr-reveals-insights-for-2

Additionally, the rising number of emergency use authorizations (EUAs) for diagnostic kits & devices developments support by the non-medical device and diagnostic companies expatiate the market size. On the other hand, high costs of the diagnostics and stringent regulatory norms are the major factors expected to impede the market growth. Also, the rising numbers of new entrants with absolutely limited medical equipment business history act as a sizable headwind for the growth of the market.

Additionally, factors such as the considerable price gap between the top players and small unorganized players inhibit market growth. Nevertheless, continuous technological advancements and rising demand for quick test results would support the market growth throughout the review period. Furthermore, increasing governmental endeavors to spread awareness about the epidemic and the necessary care regime propel the growth of the market.

Global COVID-19 Diagnostics Market – Segments

The report is segmented into four dynamics;

By Type: Molecular Tests and Serology Tests.

By Technology: RT PCR, Isothermal Amplification, CRISPR, ELISA, Hybridization, and others.

By End User: Hospitals, Public Health Labs, Private or Commercial Labs, and others.

By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World.

Global COVID-19 Diagnostics Market – Geographical Analysis

Europe dominates the global COVID-19 diagnostics market. The largest market share attributes to the high number of coronavirus infected patients in the region. Besides, the high COVID-19 morbidity and mortality observed among residents in long-term care facilities (LTCF) in EU/EEA countries increase the market demand, posing challenges for disease prevention and control. Moreover, the wide availability of diagnostics for immediate detection of COVID-19 cases fosters the growth of the regional market.

Additionally, the rising government funding and support from the government for research & development of diagnostic tests, innovations, and treatments for the virus boost the regional market growth. Furthermore, the strong presence of industry players and well-established healthcare sectors, alongside the rising healthcare expenses in the region, bolster the market growth. The European COVID-19 diagnostics market is projected to retain its dominance over the global market throughout the estimated period.

North America holds the second-largest share in the global COVID-19 diagnostics market. The market is driven by the rapid outbreak of highly infectious acute respiratory disease due to coronavirus. Moreover, the presence of key industry players and rising product launches boost the growth of the regional market. Additionally, rising strategic alliances between key players and well-spread awareness about COVID-19, fuel the regional market growth. Additionally, the involvement of non-profit organizations to control the pandemic and well-established healthcare infrastructure in the region boosts the market growth.

The COVID-19 diagnostics market in the Asia Pacific region is quadrupling rapidly. Despite several adversaries, the APAC market is still surging rapidly due to the ongoing programs to increase awareness among people, developments in healthcare, and the growing per capita healthcare expenditure in the region. Furthermore, growing numbers of COVID-19 cases and government & private funding for research & development for effective diagnosis propel the regional market growth.

The rising adoption of advanced technology and the availability of affordable treatment options in India and China substantiate regional market growth. With the increasing investments in healthcare, the APAC COVID-19 diagnostics market is forecasted to grow at an impressive CAGR during the review period.

Global COVID-19 Diagnostics Market – Competitive Analysis

Highly competitive, the COVID-19 diagnostics market appears to be widely expanded with the presence of many players. Expected extensions in products & services would drive the competition in the market, intensifying it further. This market demonstrates pretty good growth prospects that are expected to attract new entrants, introducing the market with fierce competition.

COVID-19 Diagnostics Market Major Players:

Players leading the global COVID-19 diagnostics market are Bio-Rad Laboratories (US), Becton, Dickinson & Company (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Biomerieux SA (France), Thermo Fisher Scientific (US), Genmark Diagnostics (US), Qiagen (Germany), and Siemens AG (Germany), among others.

COVID-19 Diagnostics Industry/ Innovations/ Related News

July 24, 2020 —– Vishat Diagnostic Pvt. Ltd. (India), a leading global diagnostic solution provider, announced receiving the approval from the Indian Council of Medical Research (ICMR) for supplying rapid testing COVID-19 antigen kit developed by Coris BioConcept. The new rapid testing antigen kit works with both oral and nasal swabs, giving the results in a short span of 15 minutes.

The kit was developed by Belgium-based firm Coris BioConcept and is used in several European and North American countries. When India is touching its peak in daily numbers of cases, it becomes critical to increase testing rapidly. Hence the company is bringing CE certified, and ICMR approved COVID-19 Ag Respi-Strip, kits at affordable prices – Rs 425 (USD5.68 only). This would help various state governments to fast pace the testing and isolation process.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/covid-19-diagnostics-market-9710

About Us:

Contact Us:

Market Research Future, Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune – 411028 Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Whole Exome Sequencing Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

Global Whole Exome Sequencing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

The global whole exome sequencing market is growing at a rapid pace. Market growth attributes to the rising usage of exome in the identification and determination of genetic variants, increasing the chances of diseases such as Miller syndrome and Alzheimer’s. Besides, the decreasing cost of sequencing and the use of whole-exome sequencing technology for varied applications, drive the market growth.

Moreover, increasing product launches and regulatory approvals escalate the growth of the market. According to Market Research Future (MRFR), the global whole exome sequencing market is expected to reach USD 2,696.03 MN by 2025, growing at 19.80% CAGR throughout the forecast period (2019 – 2025). Advantages of whole-exome sequencing procedures increase the market size.

Also Read : https://www.benzinga.com/pressreleases/20/08/ab16996919/covid-19-impact-on-whole-exome-sequencing-market-2020-global-industry-size-development-pipeline-m

Besides, rising advances in sequencing techniques allow the market to garner phenomenal traction on the global platform. Additionally, factors such as increasing cancer research, precision medicine adoption, and evolving complementary industries, foster the market share. Increasing applications such as forensic biology, biotechnology, virology, and molecular biology drive the growth of the whole exome sequencing market.

Conversely, the lack of skilled professionals and legal issues related to whole-exome sequencing are the significant factors projected to impede the market growth. Also, Factors such as insufficient R&D funds and the high cost of development & maintenance inhibit the market growth. Data safety concerns and ethical considerations restrict the growth of the market. Nevertheless, increasing private and public funding programs for R&D would support market growth throughout the review period.

Whole Exome Sequencing Market – Segments

The report is segmented into five dynamics;

By Product : Kits (DNA Fragmentation, End Repair, A-Tailing, And Size Selection Kits, Library Preparation, Target Enrichment, others), Sequencer, Services {Sequencing Services, Data Analysis (Bioinformatics), others}, and others.

By Technology : Sequencing by Synthesis (SBS), ION Semiconductor Sequencing, and others.

By Application : Diagnostics {Cancer Diagnostics, Monogenic (Mendelian) Disorders, Monogenic Types of Diabetes, Movement Disorders, HIV, others}, Drug Discovery & Development, Agriculture & Animal Research, and others.

By End User : Research Centers & Government Institutes, Hospitals & Diagnostics Centers, Pharmaceutical & Biotechnology Companies, and others.

By Regions : North America, Europe, APAC, and Rest of the World.

Whole Exome Sequencing Market – Regional Analysis

North America dominates the global whole exome sequencing market. The largest market share attributes to the high prevalence rate of cancer & other chronic disorders and high healthcare expenditure. Besides, favorable government initiatives for the development and adoption of whole-exome sequencing technologies drive the growth of the regional market. Moreover, efforts of private organizations aiming to produce genome data for researchers and precision medicine research platforms foster regional market growth.

Additionally, the presence of global players and encouraging research and development in healthcare boost regional market growth. Other factors, such as increased uptake of advanced technologies and high healthcare expenditures, substantiate the growth of the regional market. The US, backed by the rising demands for whole exome sequencing procedures, accounts for the significant growth contributor to the regional market.

Europe stands second in the global whole exome sequencing market. The market is driven by rising cancer cases and increasing programs to promote the adoption of genome sequencing. Moreover, recent advancements in the technology and the augmenting uptake of the advanced technology in the region foster the regional market.

Additionally, the presence of a well-developed medical device industry and rising healthcare expenditure facilitates regional market growth. Also, factors such as the rising support and funding from public & private sectors for research & development fuel the market growth in the region.

The Asia Pacific whole exome sequencing market is emerging as the rapidly growing market, globally. Factors such as the increasing technological advancements, per capita income, and government initiatives to improve healthcare quality, drive the regional market growth.

Furthermore, the growing patient pool and the older population in China, India, and Australia have enabled the regional market to grow promisingly. Also, the rising demand for these whole exome sequencing procedures and the increasing adoption of advanced techniques in these procedures drive the regional market growth.

Whole Exome Sequencing Market – Competitive Analysis

Highly competitive, the whole exome sequencing market appears fragmented due to the presence of many well-established players. These players adopt strategic approaches such as mergers & acquisitions, collaboration, expansion, and technology launch to strengthen their market positions.

They invest substantially in developing new technologies and upgrade their existing sequencing techniques. Also, they make substantial investments to expand their global footprints.

Whole Exome Sequencing Market Major Players

Players leading the global whole exome sequencing market include BGI (China), Illumina Inc. (US), Eurofins Scientific (Belgium), Agilent Technologies, Inc. (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Ambry Genetics (US), GENEWIZ (US), Macrogen, Inc. (South Korea), and Integragen SA (France), among others.

Whole Exome Sequencing Industry/Innovations/Related News:

July 22, 2020 —- Swift Biosciences, Inc.(the US), a leader in the commercialization of DNA & RNA library preparation kits for Next-Generation Sequencing (NGS), announced its partnership with Otogenetics Corporation, a high throughput NGS clinical lab to distribute its Swift 2S® Turbo DNA Library Kits. Otogenetics offers prenatal testing, hereditary cancer risk assessment, deafness testing, rare diseases, clinical exome, and other tests for personalized medicine & clinical trials.

The collaboration would help Otogenetics ramp its hereditary disease & personalized medicine service areas and initiatives by supercharging its clinical whole-exome sequencing (WES) offerings. The sequencing of exome allows researchers and clinicians to obtain decision-making data for genetic variants responsible for Mendelian diseases.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/whole-exome-sequencing-market-8763

About Us:

Contact Us:

Market Research Future, Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune – 411028 Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

The Healthcare Personal Protection Equipment Market Staggering Double Digit Cagr Driven By Advanced & Cost Effective Technologies Forecasts Till 2023

The exclusive research report on the Global Healthcare Personal Protection Equipment Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

The global healthcare personal protection equipment market is predicted to touch USD 10.116 billion at a 9.17% CAGR between 2019- 2027, as per the recent analysis by Market Research Future (MRFR). Personal protective equipment or PPE is a protective gear that has been designed to protect the workers’ health by reducing the exposure to biological agents. This is an essential tool to prevent transmission of infectious diseases not only in treatment centers yet also in different activities such as community care related, safe burials, waste management, and cleaning associated to the outbreak.

Also Read : https://www.benzinga.com/pressreleases/20/07/ab16723323/healthcare-personal-protection-equipment-market-to-touch-usd-10-116-billion-at-9-17-cagr-by-2027

Various factors are propelling the global healthcare personal protection equipment market growth. As per the latest MRFR report, such factors include burgeoning demand for protective clothing, respiratory protection, and hand protection in the healthcare industry for the safety of people during the current COVID-19 outbreak, rapid technological advances in surgery, standardizing procedures, increasing initiatives by the government to facilitate the import of PPE, rising production of integrated and cost-effective PPE, increasing end user demand, and the emergence of local PPE manufacturers.

On the contrary, the high price of raw materials may limit the global healthcare personal protection equipment market growth over the forecast period.

Healthcare Personal Protection Equipment Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global healthcare personal protection equipment market report based on end use and product.

By product, the global healthcare personal protection equipment market is segmented into hand protection, protective footwear, head, eye & face protection, respiratory protection, protective clothing, and others. The protective clothing segment is again sub-segmented into gowns, coveralls, and others. The respiratory protection segment is again sub-segmented into respiratory masks, surgical masks, and others. The hand protection segment is again sub-segmented into surgical, sterile gloves, chemical handling, and general-purpose. Of these, the respiratory segment will lead the market over the forecast period. The burgeoning demand for respirators and surgical masks to protect the hospital staff against contaminants and pathogens is adding to the growth of the segment.

By end use, the global healthcare personal protection equipment market is segmented into diagnostic laboratories, academic and research institutes, ambulatory surgical centers, hospitals and clinics, and others. Of these, hospitals & clinics will command the largest share in the market over the forecast period. The growing number of doctors in the emerging economies and people opting for medical services for treatment are adding to the growth of the segment.

Healthcare Personal Protection Equipment Market Regional Analysis

Based on the region, the global healthcare personal protection equipment market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific, & the Middle East and Africa. Of these, the Americas will command the largest share over the forecast period. Rising prevalence of the COVID-19 infection, growing concerns with regards to the safety & health of healthcare professionals, and rising government initiatives are adding to the global healthcare personal protection equipment market growth in the region.

The global healthcare personal protection equipment market in Europe is predicted to hold the second-largest share over the forecast period. An increase in healthcare expenditure resulting in the growth both in production and consumption of medical products & devices are adding to the global healthcare personal protection equipment market growth in the region.

The global healthcare personal protection equipment market in the APAC region is predicted to grow at a fast pace over the forecast period. High target population, government’s rising focus towards healthcare facilities, technological advances, and the presence of emerging market players are adding to the global healthcare personal protection equipment market growth in the region.

The global healthcare personal protection equipment market in the MEA is predicted to have sound growth over the forecast period for the high penetration of PPE in the developed healthcare industries of South Africa & the UAE.

Healthcare Personal Protection Equipment Market Key Players

Leading players profiled in the healthcare personal protection equipment market report include KOWA (Japan), Med-Con (Australia), priMED Medical Products, Inc. (Canada), Halyard Health, Kimberly-Clark Worldwide, Inc. (US), Plasti Surge Industries Pvt. (India), Alpha Pro Tech (Canada), Medisca Inc. (US), Crosstex International, Inc. (US), DuPont (US), Sterimed (US), Ansell (Australia), Medtronic PLC (Ireland), Honeywell International Inc. (US), and 3M (US).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/healthcare-personal-protection-equipment-market-9594

About Us:

Contact Us:

Market Research Future, Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune – 411028 Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Particle Counter Market Statistical Analysis In 2020 By International Top 10 Players Till 2023

An expert on premium research reports, Market Research Future has added a report titled "Global Particle Counter Market 2023" to its offering.

The obsession with cleanroom technology across industrial sectors has led to the development of products able to track contaminants. Presence of contaminants can dilute solutions or send out wrong readings in sensitive environments. Particle counters are instruments which can detect and count physical particles. It can calculate the volume of particles in the air in cleanrooms and workplaces. Market Research Future (MRFR) has outlined the various factors and restraints enveloping the global particle counter market in its latest report as well as predictions for the period of 2019 to 2025 (forecast period). The pervasion of the COVID-19 and its effects are analyzed in detail in the report.

Particle Counter Market Scope

Global particle counter market size is expected to cross USD 168.2 Million by 2025 at a CAGR of 7.1% during the forecast period of 2019 to 2025.

Also Read : https://www.medgadget.com/2020/06/covid-19-pandemic-to-leverage-growth-of-particle-counter-market-2020-industry-analysis-growth-size-regional-outlook-top-companies-competitive-landscape-future-trends-by-2025.html

Production of drugs, vaccines, and other chemicals by chemicals, pharmaceuticals, and other industries can drive the need for particle counters. Strict regulations pertaining to the removal of contaminants and removal of harmful bacteria can push the market demand greatly. Investments in research and development activities can fuel market demand as well. According to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) had invested close to USD 4.46 billion in 2015.

But high costs of particle counters can limit market growth.

Particle Counter Market Competition

key players of the global particle counter market are –

Climet Instruments Company
Lighthouse Worldwide Solutions Inc.
Setra Systems
TSI Incorporated
Met One Instruments Inc.
Chemtrac Inc.
Particle Measuring Systems Inc.
Rion Co. Ltd.
Beckman Coulter

Particle Counter Market Segmentation

The global particle counter market is segmented by product type, modularity, technology, and end user.

By product type, it is divided into liquid and airborne particle counters. Airborne particle counters are expected to take the lead in the market till 2025. This can be attributed to its sensitivity towards dust particles and ability to monitor room contamination. On the other hand, liquid particle counters can capture a significant market share owing to application in automotive, heavy machinery, and aviation & space exploration.

By modularity, it is segmented into handheld, portable, and remote particle counters.

By technology, it is divided into offline and online particle counters. Online particle counters can hold maximum market share owing to its ability to detect particles in lubricating and hydraulic systems.

By end user, it is segmented into pharmaceutical industry, medical device industry, research laboratories, and others.

Particle Counter Market Regional Analysis

Europe, the Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA) are prime regions considered in the global particle counter market.

The Americas held the largest market share in 2018. It is likely to dominate the market during the forecast period owing to adoption of particle counters and regulations enforced by federal agencies. Launch of new products by players and expansion of product portfolios can encourage market growth.

Europe is expected to induce heavy demand for the global market due to the need for particle counters in medical device and pharmaceutical industries. The large population, a spike in healthcare spending, and support from governments are primary drivers of the regional market.

APAC accounted for the third position in the market due to investments by American and European stalwarts, developments in healthcare manufacturers, large number of research organizations, low manufacturing costs, and economical labor costs.

The MEA region accounted for the lowest market share due to limited investments in modernization of healthcare infrastructure.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/particle-counter-market-8776

About Us:

Contact Us:

Market Research Future, Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune – 411028 Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com